Page last updated: 2024-11-04

rofecoxib and Gastritis

rofecoxib has been researched along with Gastritis in 9 studies

Gastritis: Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders.

Research Excerpts

ExcerptRelevanceReference
" In the present study, we examined the effect of various COX inhibitors on gastric ulcerogenic and acid secretory responses following daily exposure of the stomach to iodoacetamide (IA) and investigated the role for COX isozyme in gastric protection under subchronic mucosal irritation."3.72Roles of endogenous prostaglandins and cyclooxygenase izoenzymes in mucosal defense of inflamed rat stomach. ( Hayashi, Y; Murakami, M; Takeeda, M; Takeuchi, K; Yamato, M, 2004)
"In indomethacin and rofecoxib-treated gerbils, the following results were obtained in H pylori-infected group vs H pylori-eradicated group respectively: hyperplasia area of the stomach (mm2): 82."1.33Eradication of Helicobacter pylori significantly reduced gastric damage in nonsteroidal anti-inflammatory drug-treated Mongolian gerbils. ( Chang, CC; Chen, SH; Fang, CL; Hsieh, CR; Lien, GS; Lou, HY; Pan, S, 2005)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ranatunge, RR1
Augustyniak, M1
Bandarage, UK1
Earl, RA1
Ellis, JL1
Garvey, DS1
Janero, DR1
Letts, LG1
Martino, AM1
Murty, MG1
Richardson, SK1
Schroeder, JD1
Shumway, MJ1
Tam, SW1
Trocha, AM1
Young, DV1
Souza, MH1
de Lima, OM1
Zamuner, SR1
Fiorucci, S1
Wallace, JL1
Scheiman, JM1
Greenson, JK1
Lee, J1
Cryer, B1
Takeeda, M1
Hayashi, Y1
Yamato, M1
Murakami, M1
Takeuchi, K1
Lugardon, S1
Lapeyre-Mestre, M1
Montastruc, JL1
Chang, CC1
Chen, SH1
Lien, GS1
Lou, HY1
Hsieh, CR1
Fang, CL1
Pan, S1
Moride, Y1
Ducruet, T1
Boivin, JF1
Moore, N1
Perreault, S1
Zhao, S1
Swaak, AJ1
Theunissen, DJ1
Fendrick, AM1

Reviews

1 review available for rofecoxib and Gastritis

ArticleYear
Developing an economic rationale for the use of selective COX-2 inhibitors for patients at risk for NSAID gastropathy.
    Cleveland Clinic journal of medicine, 2002, Volume: 69 Suppl 1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Clinical Trials as Topic; Cost-Benefit Analysis;

2002

Other Studies

8 other studies available for rofecoxib and Gastritis

ArticleYear
Synthesis and selective cyclooxygenase-2 inhibitory activity of a series of novel, nitric oxide donor-containing pyrazoles.
    Journal of medicinal chemistry, 2004, Apr-22, Volume: 47, Issue:9

    Topics: Administration, Oral; Animals; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cycl

2004
Gastritis increases resistance to aspirin-induced mucosal injury via COX-2-mediated lipoxin synthesis.
    American journal of physiology. Gastrointestinal and liver physiology, 2003, Volume: 285, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Adhesion; Cyclooxygenase 2; Cyclooxy

2003
Effect of cyclooxygenase-2 inhibition on human Helicobacter pylori gastritis: mechanisms underlying gastrointestinal safety and implications for cancer chemoprevention.
    Alimentary pharmacology & therapeutics, 2003, Jun-15, Volume: 17, Issue:12

    Topics: Adult; Cell Division; Cyclooxygenase 2; Dinoprostone; Endoscopy, Gastrointestinal; Female; Follow-Up

2003
Roles of endogenous prostaglandins and cyclooxygenase izoenzymes in mucosal defense of inflamed rat stomach.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2004, Volume: 55, Issue:1 Pt 2

    Topics: Administration, Oral; Animals; Body Weight; Capsaicin; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxyg

2004
Upper gastrointestinal adverse drug reactions and cyclo-oxygenase-2 inhibitors (celecoxib and rofecoxib): a case/non-case study from the French Pharmacovigilance Database.
    European journal of clinical pharmacology, 2004, Volume: 60, Issue:9

    Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Celecoxib; Cyclooxygenase 2; Cyclo

2004
Eradication of Helicobacter pylori significantly reduced gastric damage in nonsteroidal anti-inflammatory drug-treated Mongolian gerbils.
    World journal of gastroenterology, 2005, Jan-07, Volume: 11, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Chronic Diseas

2005
Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study.
    Arthritis research & therapy, 2005, Volume: 7, Issue:2

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Ca

2005
[Safety of specific cyclo-oxygenase 2 inhibitors].
    Nederlands tijdschrift voor geneeskunde, 2001, Jul-28, Volume: 145, Issue:30

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cost-Benefit Analysis; Cyclooxygenase I

2001